This study is in progress, not accepting new patients

Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study

a study on Breast Cancer

Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at UCSF
Dates
study started
completion around

Description

Summary

There is no granular retrospective data on breast cancer in transgender and gender-diverse (TGD) persons from a contemporary and diverse American cohort. The purpose of this investigation is to aggregate data from multiple institutions to describe the risk, diagnosis, management, and outcomes of TGD persons with breast cancer in effort to identify opportunities for future intervention studies to eliminate breast cancer disparities for this population.

Official Title

A Multi-Institutional Retrospect Cohort Study of Breast Cancer Diagnosis and Management in Transgender and Gender-Diverse Individuals

Keywords

Breast Cancer, Breast Neoplasms, Breast Adenocarcinoma, Breast Cancer Stage, Breast Cancer Stage IV, Breast Cancer Invasive, Breast Cancer in Situ, Transgender, Nonbinary, Gender Diverse, Gender-Affirming Hormone Therapy, Carcinoma in Situ, Breast Carcinoma In Situ

Eligibility

You can join if…

Open to people ages 18 years and up

  1. Age 18 years of age or older
  2. Breast cancer diagnosis (including DCIS)
  3. Persons who identify as gender and/or sex that is different from the sex they were assigned at birth

You CAN'T join if...

  1. Age <18 at time of breast cancer diagnosis
  2. Cis-gendered persons

Locations

  • University of California San Francisco (UCSF)
    San Francisco California 94115 United States
  • University of Washington (UW)
    Seattle Washington 98195 United States

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Medical College of Wisconsin
ID
NCT06234488
Study Type
Observational
Participants
Expecting 125 study participants
Last Updated